About Us
JIU ZHANG
Jiuzhang Biotech is a research-based innovative pharmaceutical company

Founded in 1999, Sichuan Jiuzhang Biotechnology Co.,Ltd. is an innovative pharmaceutical enterprise integrating scientific research production, sales and health services.

Guided by natural objectivity and respect for the laws of life, valuing  the  holistic medical concept and functional medicine, Jiuzhang Biotech has focused on innovative research of non-toxic plants originating from natural for over two decades. Leveraging its proprietary extraction, separation, and purification technology platform for oxidation-prone medicinal natural products, Jiuzhang Biotech has selected multiple natural substances, with CHA as the representative candidate, for natural drug development. Notably, Jiuzhang Biotech pioneered the global application of CHA ( a compound widely found in plants)  in the research and development of therapies for major diseases, including cancers, neurological disorders,  autoimmune diseases and metabolic diseases.

JIU ZHANG
Production Base of Eucommia Ulmoides Leaves

Eucommia ulmoides leaves are the raw material for the extraction, separation, and purification of chlorogenic acid API, and their quality directly affects the quality and efficacy of chlorogenic acid. The eucommia ulmoides planting bases of Jiuzhang Biotech are mainly distributed in areas with concentrated eucommia ulmoides resources in Sichuan Province, including Wangcang, Beichuan, and Bazhong. These regions, with their favorable climates and fertile soils, provide unique natural conditions for the growth of eucommia ulmoides.

Jiuzhang Biotech always adheres to the principles of "organic cultivation" and "standardized management", striving to ensure the high quality of eucommia ulmoides leaves from the source. During the process, the Company strictly adheres to organic agriculture standards, completely avoids the use of chemical pesticides and fertilizers, and employs natural organic fertilizers and biological control techniques to ensure medicinal purity, and overall safety of eucommia ulmoides leaves. Jiuzhang Biotech has also established a comprehensive planting management system, implementing standardized operations in every step from seed selection, seedling cultivation, planting, to harvesting, preliminary processing, and storage, to ensure that the active ingredient content in eucommia ulmoides leaves remains stable and meets medicinal requirements.

JIU ZHANG
Manufacturer of chlorogenic acid for injection

The chlorogenic acid for injection is a high-quality pharmaceutical product produced by Chengdu Tongde Pharmaceutical Co., Ltd. under the commission of Jiuzhang Biotech as the Marketing Authorization Holder (MAH). Jiuzhang Biotech always adheres to the principles of "Quality First" and "Green Production", strictly follows the Good Manufacturing Practice (GMP) for pharmaceuticals to ensure that every link from raw materials and excipients procurement to production processes meets the highest standards. The Company is committed to providing patients with safe, effective, and high-quality medicines through a scientific and rigorous approach, coupled with advanced technology.

Team
Introduction to core team
Operation team of Jiuzhang Biotech
Technical team of Jiuzhang Biotech
Mechanism research team
Clinical research team
  • Zhang Jie
    Chairman and General Manager
    Founder, the originator of CHA API and CHA for injection
  • Yang Huarong
    Chief Technical Officer for Clinic
    Overall management of preclinical research and clinical trials
  • Huang Wang
    Quality Director
    Pharmaceutical research and quality control of CHA API and CHA for injection
  • Liao Juan
    Head of Business Department
    Management of product and project promotion channels and sales support
  • Wang Xiyi
    Head of International Business Department
    Formulating and implementing enterprise globalization and brand internationalization
  • Liu Mingjie
    Head of Clinical Department
    Director of Clinical Project Management of Glioma
  • Zhu Lina
    Head of Registration Department
    Product registration/filing and regulatory affairs
  • Kang Li
    Treasurer
    Fund management and risk control of the Company
  • Liu Youqin
    Head of Administration and Personnel
    Institutional development and human resources of the Company
  • Zhang Jie
    The originator of CHA API and CHA for injection
  • Yang Huarong
    Chief Technical Officer for Clinic
  • Liu Mingjie
    Director of Clinical Project Management of Glioma
  • Zhou Yitao
    Clinical project management of glioma
  • Zhang Liang
    Head of Technical Risk Control
  • Huang Wang
    Pharmacy Director
  • Zhang Fei
    Quality Director
  • Zhu Lina
    Drug Registration Director
  • Zhang Ya
    Technical Director
  • Jiang Jiandong
    Academician of the China Academy of Engineering
    Chief Scientist of Jiuzhang Biotech, specialized in mechanism research of natural drugs
  • Li Wenbin
    Professor, Doctoral Tutor
    Core Researcher in Clinical and Mechanism Studies of CHA
  • Zhang Jie
    Chairman and General Manager
    The originator of CHA API and CHA for injection
  • Yang Huarong
    Chief Technical Officer for Clinic
    Overall management of preclinical research and clinical trials
  • Deng Jing
    Postdoctoral Fellow
    Senior Researcher, specialized in anti-tumor mechanism studies
  • Li Wenbin
    Professor , Doctoral Tutor
    Director of Comprehensive Cancer Treatment Center of Beijing Tiantan Hospital, Core Researcher in Clinical and Mechanism Studies of CHA
  • Kang Zhuang
    Deputy Chief Physician, PhD
    SUBI at Beijing Tiantan Hospital
  • Li Mo
    Attending Physician, Postdoctoral Fellow
    SUBI at Beijing Tiantan Hospital
  • Cai Run
    Chief Physician, PhD
    PI at Chongqing University Cancer Hospital
  • Mao Deqiang
    Chief Physician, PhD
    PI at Chongqing University Cancer Hospital
  • Li Weiping
    Chief Physician, Doctoral Tutor
    PI at Shenzhen Second People’s Hospital
  • Ao Rui
    Chief Physician, PhD
    PI at Sichuan Provincial People’s Hospital
  • Liu Xiaomin
    Chief Physician, PhD
    PI at Tianjin Huanhu Hospital
Business Partners
Domestic Coop. Unit
Honors
Honors
  • Demonstration Project of Major Scientific and Technological Achievement Transformation in Sichuan Province
  • Project Approval Certificate of Technological Innovation Fund for Small and Medium-sized Enterprises
  • Sichuan Provincial Key Technological Innovation Project
  • Sichuan Provincial Key Technological Innovation Project
  • Certificate of National-level Torch Program project
  • Certificate of Appraisal of Scientific and Technological Achievement
2013

Demonstration Project of Major Scientific and Technological Achievement Transformation in Sichuan Province

2009

Project Approval Certificate of Technological Innovation Fund for Small and Medium-sized Enterprises

2007

Sichuan Provincial Key Technological Innovation Project

2007

Sichuan Provincial Key Technological Innovation Project

2005

Certificate of National-level Torch Program project

2003

Certificate of Appraisal of Scientific and Technological Achievement